# Implanet and SeaSpine sign 6-year private label agreement for Jazz spinal devices in US

Implanet entered into a 6-year private label agreement with SeaSpine for distribution of the Jazz portfolio in the U.S. SeaSpine will have exclusive rights to sell Jazz products under its own brand name, including the Jazz Cap implant upon FDA clearance.

- Type: Contract
- Announced: 2019-02-21
- Where: United States
- Status: completed
- Products: Jazz spinal implants, Jazz Cap implant
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Implanet](https://endata.com/companies/37493.md) (supplier)
- [SeaSpine](https://endata.com/companies/37494.md) (customer)

## Sources

- [orthoworld.com](https://www.orthoworld.com/seaspine-implanet-form-us-partnership-with-jazz-spina-devices/), 2019-02-21: "Implanet entered into a 6-year private label agreement with SeaSpine covering distribution of the Jazz® portfolio in the U.S."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.